Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-FR Version v1-EN
Language French English
Date Updated 2022-08-15 2022-06-08
Drug Identification Number 02517132 02517132
Brand name DEXTROSE INJECTION DEXTROSE INJECTION
Common or Proper name DEXTROSE INJECTION 500MG/ML (50%) DEXTROSE INJECTION 500MG/ML (50%)
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients DEXTROSE DEXTROSE
Strength(s) 50% 50%
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 X 50ML VIALS / FIOLES 10 X 50ML VIALS / FIOLES
ATC code B05BA B05BA
ATC description I.V. SOLUTIONS I.V. SOLUTIONS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2022-06-20 2022-06-20
Actual start date 2022-06-16
Estimated end date 2022-08-11 2022-07-27
Actual end date 2022-08-11
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments